Form4insider filings, from the source

SEC Form 4 · accession 0001808343-26-000007

Immunome Inc. · IMNM

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Jul 6, 2026
Accepted (ET)
Jul 7, 2026 · 7:02 pm EDT
Rule 10b5-1 plan
yes — trade under a plan
Issuer CIK
0001472012

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2,F3Jul 6, 2026S83,094$24.11D125,410ISee footnote
Common StockF4,F3Jul 7, 2026S16,906$24.20D108,504ISee footnote
Common Stockholding———103,259D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses